Satori raises $15 million

Alzheimer's disease company Satori Pharmaceuticals Inc. (Cambridge, Mass.) raised $15 million in a financing co-led by existing investors InterWest Partners; New Enterprise Associates; and Prospect Venture Partners. Satori also appointed Donald Hayden, a director, as chairman. He is a senior advisor to Prospect Venture Partners. PureTech Ventures' Stephen Muniz and Prospect Venture's David Schnell joined Satori's board. PureTech is an existing investor. ...